Malaysia Kidney Function Test Market to be Dominated by Increasing Diabetes and Hypertension
Rising
prevalence of kidney disorders and increasing technological advancements is
expected to drive the Malaysia kidney function test market in the forecast
period 2024-2028.
According to TechSci Research
report, “Malaysia
Kidney Function Test Market – By Region, Competition,
Forecast and Opportunities, 2028”, the Malaysia kidney
function test market is anticipated to grow at a significant rate in the
forecast period, 2024-2028. The driving force behind
this growth is the rising incidence of diabetes and hypertension in the
country. Both of these conditions can lead to kidney disease, making regular
kidney function tests essential for anyone with these conditions. Hypertension, or high blood pressure, is another
leading cause of kidney disease. Hypertension can cause damage to the small
blood vessels in the kidneys, leading to reduced kidney function over time. To
detect kidney disease early, regular kidney function tests are crucial. These
tests measure the levels of various substances in the blood, such as creatinine
and blood urea nitrogen, which can indicate how well the kidneys are
functioning. If kidney disease is detected early, it can often be managed
effectively, allowing people with this condition to live full and healthy
lives. As the incidence of diabetes and hypertension continues to rise in
Malaysia, the demand for kidney function tests is expected to increase
significantly. This is driving growth in the kidney function test market, with
many companies expanding their offerings in this area to meet the growing
demand. The Malaysian government has recognized the importance of kidney
disease prevention and management, with several initiatives aimed at improving
access to kidney function tests for those at risk. For example, the Ministry of
Health has launched the “OhMyGinjal”, which aims to raise awareness of the
importance of kidney health and encourage people to get regular kidney function
tests. Furthermore, current technological developments in the healthcare
industry, particularly those pertaining to diabetes, is likely to fuel the Malaysia
kidney function test market over the forecast period.
However, the unavailability of skilled
professionals leads to false results and its inaccessibility in rural areas
with limited coverage can be a barrier to access for some individuals,
particularly those from low-income backgrounds, may hamper the growth of
the market in the forecast period.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Malaysia Kidney Function Test Market “
The Malaysia Kidney
Function Test Market is segmented based on type, component, end user, and company.
Based on type, the market is divided into urine tests and blood tests. The urine tests segment is expected to witness a rise over the forecast
period. This is attributed to the fact that urine tests are usually performed
to check albumin protein in our body. The doctor can determine the best course
of treatment for the patient by checking the albumin levels in the urine. If
the level of urine albumin remains unchanged or decreases, therapies may be
effective, which is anticipated to support market growth in the future.
Based on component,
the market is divided into dipsticks, reagents, kits & assays, and others. The dipsticks segment is expected to witness
a rise over the forecast period. This is attributed to the cost effectiveness
and its ability to check for acidity, concentration, protein, sugar, ketones, bilirubin, evidence
of infection, and blood in urine.
Based on end user,
the market is divided into hospitals
& clinics, diagnostic laboratories and others. The hospitals & clinics segment is
expected to witness a rise over the forecast period. This is attributed to the availability
of skilled professionals and high quality testing equipment available in
hospitals and clinics. Also, people rely on prescriptions for testing and
diagnosis.
Major
companies operating in Malaysia kidney function test market are:
- Siemens Healthcare Private Limited
- Pfizer Inc
- Abbott Laboratories, Inc
- Danaher Corporation
- bioMérieux Malaysia Sdn Bhd
- Astrazeneca Sdn. Bhd.
Download Free Sample Report
Customers can also request 10% free customization in this
report.
“Malaysia kidney function test market is expected to
witness a significant growth in the upcoming years, due to the growing prevalence
of chronic kidney disorders in the nation. In Malaysia, the health care system
is controlled by the Ministry of Health which means that diagnosis and testing
are deemed to be reliable, safe, and effective. The increasing geriatric population
and rising prevalence of diabetes and hypertension will drive a notable market
segment in Malaysia. Also, technological advancements in the medical diagnostics,
in turn, strengthens the growth of the market, which is expected to grow through,
2028” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based
global management consulting firm.
“Malaysia Kidney Function Test
Market, By Type (Urine Tests, Blood Tests), By Component (Dipsticks, Reagents,
Kits & Assays, and Others), By End User (Hospitals & Clinics,
Diagnostic Laboratories, and Others), By Region, Competition, Forecast and
Opportunities, 2028”, has evaluated the future
growth potential of Malaysia Kidney Function Test Market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Malaysia Kidney Function Test Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com